Story Highlight
– Amelia-Rose suffered severe asthma since three months old.
– Combination inhalers transformed her asthma management and life.
– Research shows they halve asthma attack risks in children.
– New UK study to examine combination inhalers for kids.
– Parents encouraged to ask about combined inhalers for children.
Full Story
Sophie Hafford, a mother of four from Manchester, faced ongoing heartache watching her daughter Amelia-Rose battle severe asthma from a young age. Now six years old, Amelia-Rose’s asthma has been a constant challenge since she was just three months old. Airway inflammation led to frequent hospital visits; on average, the young girl would be admitted every two weeks, with stays lasting from several days to a couple of weeks. This overwhelming situation had forced Sophie to make countless emergency ambulance calls as Amelia-Rose struggled to breathe.
The severity of her daughter’s asthma meant that high-dose steroid tablets were often prescribed to help control the inflammation in her airways. However, Sophie expressed her concerns over potential side effects from these powerful medications, including weight gain and the risk of impacting Amelia-Rose’s growth. “There were times when I thought I’d lose her during an attack because she deteriorated so quickly,” said the 31-year-old.
Asthma affects approximately two million children across the UK, with a significant portion, around 100,000, suffering from severe cases like that of Amelia-Rose, according to Asthma and Lung UK. Asthma involves the inflammation and constriction of the airways when exposed to certain triggers, including pollen, dust mites, and pet dander. Despite these difficulties, there has been a marked change in Amelia-Rose’s condition over the past year, largely attributed to a new inhaler regimen.
Having been diagnosed at three years old, Amelia-Rose was initially on a typical blue reliever inhaler, which contained salbutamol, designed to quickly alleviate symptoms by relaxing the airways. She also used a brown preventer inhaler, which was to be taken twice daily and contained lower doses of steroids aimed at reducing inflammation. However, in 2024, her medical team switched her to a combination inhaler, a change that has proven to be life-changing.
Combination inhalers offer dual medication: they include steroids to address inflammation alongside both short-acting and long-acting bronchodilators, such as formoterol. These inhalers are taken at scheduled times for overall management, as well as on an ‘as-needed’ basis for acute symptoms, significantly simplifying medication routines. This new method, known as maintenance and reliever therapy (MART), effectively addresses two treatment needs with a single inhaler, which has been found to improve adherence to treatment plans.
Dr Andy Whittamore, a GP from Portsmouth and the clinical lead at Asthma and Lung UK, emphasised a crucial issue regarding traditional inhaler use: many patients do not adequately use their preventer inhalers. This oversight can lead to dangerous reliance on reliever inhalers, which provide immediate but temporary relief. “We know that reliever inhalers work very quickly so people get a good response and trust them,” he noted, explaining that this reaction may lead to a cycle of ineffective long-term management due to untreated underlying inflammation.
In addition, Professor Louise Fleming, a respiratory consultant at Imperial College Healthcare NHS Trust, cautioned about the dangers of overusing short-acting reliever inhalers. Such overuse can lead to harm, including increased anxiety and symptoms like elevated heart rates. Conversely, combination inhalers eliminate the need for short-acting relievers like salbutamol, therefore reducing the risk of dependence.
Research highlighted in September’s edition of The Lancet revealed that combination inhalers significantly lowered the risk of serious asthma attacks among children. A trial conducted with 360 children in New Zealand found that those using a combination inhaler featuring both a low-dose steroid and formoterol experienced a 45% reduction in asthma attacks compared to those relying solely on salbutamol. Notably, the growth and lung function of the children using combination inhalers remained unaffected.
While combination inhalers for adults and those aged twelve and over have become the norm, their availability for younger children has been limited. This is primarily due to a historical lack of robust research into their safety and effectiveness in this age group, although recent developments have led to the approval of certain combination inhalers for children aged six to eleven with moderate asthma.
The urgent call for better asthma management for children is supported by statistics showing more than 16,000 admissions of children aged fifteen and under to hospitals in England for asthma-related issues in 2024-2025. Experts highlight the necessity for healthcare practitioners to consider combination inhalers more widely, especially after the encouraging findings from New Zealand.
Current studies in the UK, spearheaded by Imperial College London, are now set to explore the safety and efficacy of varying doses of combination inhalers for children with different severities of asthma. This research aims to recruit around 1,350 young participants, with half receiving combination inhalers and the remaining patients continuing on their existing treatments.
Nevertheless, challenges remain in adopting combination inhalers as standard care for all children with asthma. Correct usage is vital, yet many parents find it difficult; for effective inhalation, combination inhalers are best used with spacers, tools that ensure more efficient delivery of medication. Professor Andrew Bush advocates for parents to discuss the possibility of using combination inhalers with their GP, particularly if their children are over the age of five.
Amelia-Rose’s journey took a positive turn upon her transition to a combination inhaler. Previously managing multiple medications, including preventers, relievers, and steroids, Sophie experienced significant stress as she meticulously prepared her daughter’s medication daily. “She missed a lot of school due to poor health and being in hospital,” Sophie recalled. The switch to a combination inhaler, recommended by a specialist when Amelia-Rose turned five, resulted in dramatic improvements in her health.
Sophie remarked, “As soon as she gets wheezy or starts coughing, she uses it and then she’s like a different child.” Now, she no longer requires steroid tablets and has been taken off her other medications. With her asthma now under control, Amelia-Rose enjoys improved school attendance and the freedom to play with friends without discomfort, allowing her to experience a more typical childhood.
As the ongoing research into combination inhalers for younger patients unfolds, it stands to offer hope for many families who are navigating the complexities of asthma management, ensuring that children like Amelia-Rose can live healthier and more fulfilling lives.
Our Thoughts
The article highlights significant issues regarding the management of asthma in children, particularly focusing on the move towards combination inhalers. To improve asthma management and prevent severe cases like Amelia-Rose’s, several measures could be considered:
1. **Improved Prescription Practices**: There should be greater consistency in prescribing combination inhalers for children, particularly in the age group under 12, as their benefits in reducing asthma attacks are clear. This aligns with the Health and Safety at Work Act 1974, which emphasizes the duty of care to ensure safe working conditions, including health management for children.
2. **Patient Education**: Enhanced education for parents and children about the proper use of medications, including maximum doses for inhalers, can minimize reliance on reliever inhalers. This addresses the Management of Health and Safety at Work Regulations 1999, which requires sufficient training and information.
3. **Regular Monitoring and Reviews**: Regular health reviews to monitor asthma management effectiveness and medication adherence should be mandated. This supports compliance with the NHS Standard Contract, which requires providers to deliver safe and effective care.
4. **Use of Spacers**: Encouraging the use of spacers with inhalers could improve delivery and efficacy, thereby reducing hospital admissions linked to poor medication use.
By implementing these recommendations, similar respiratory incidents could be mitigated, leading to safer health outcomes for children with asthma in the UK.
